share_log

Lake Street Maintains Buy on Achieve Life Sciences, Lowers Price Target to $19

Lake Street Maintains Buy on Achieve Life Sciences, Lowers Price Target to $19

Lake Street維持對Achive Life Sciences的買入,將目標
Benzinga ·  2023/05/31 09:30

Lake Street analyst Thomas Flaten maintains Achieve Life Sciences (NASDAQ:ACHV) with a Buy and lowers the price target from $22 to $19.

湖街分析師托馬斯·弗拉滕維持Achieve Life Sciences(納斯達克股票代碼:ACHV)的買入,並將目標股價從22美元下調至19美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論